About 400 reports

  • CLINICAL TRIAL PROFILE SNAPSHOTS

In addition, markers of fibrosis (Enhanced Liver Fibrosis (ELF) Score, PIIINP, TIMP-## and PRO-C##) were also reduced in both NGM## cohorts, with the greatest effect in patients with more severe disease and greater risk of disease progression.

  • Autoimmune Disease
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • ENCELADUS PHARMACEUTICALS BV
  • PH-5 - DRUG PROFILE

Ulcerative Colitis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H1 2018, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape. Ulcerative Colitis...

  • Autoimmune Disease
  • United States
  • Company
  • Product Initiative
  • Pfizer Inc.
  • PH-5 - DRUG PROFILE
  • CROHN'S DISEASE (REGIONAL ENTERITIS)

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides an overview of the Crohn’s Disease (Regional Enteritis) (Gastrointestinal)...

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • Small Molecules to Agonize ROR-Gamma for Autoimmune Disease

Biogen, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Biogen, Inc. - Product Pipeline Review - 2016’, provides an overview of the Biogen, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Biogen,...

  • Autoimmune Disease
  • Therapy
  • United States
  • World
  • Biogen Idec Inc.
  • WEGENER POLYANGIITIS - PIPELINE BY BIONOVIS SA, H1 2016
  • CHEMOCENTRYX, INC.

The company' s lead product, Infliximab, is used in the treatment of autoimmune diseases such as rheumatoid arthritis, Crohn' s disease, psoriatic arthritis and plaque psoriasis.

  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative
  • PIPELINE BY ABEOME CORPORATION, H2 2016
  • ABEOME CORPORATION

Dysregulated cytokine expression and signaling are major contributors to a number of autoimmune diseases.

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Novartis AG
  • Feb 26, 2018: DURECT Announces Patient Dosing in Phase 2a Trial of DUR-928 in Primary Sclerosing Cholangitis

Yimam, Medical Director, Autoimmune Liver Disease Program at California Pacific Medical Center, Department of Hepatology and Liver Transplantation, San Francisco, CA.

  • Autoimmune Disease
  • Pharmaceutical
  • United States
  • Company
  • DURECT Corporation

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • TE-2232 - DRUG PROFILE
  • JAN 04, 2017: INFLARX INITIATES EXPLORATORY PHASE II TRIAL WITH IFX-1, A FIRST-IN-CLASS ANTI-COMPLEMENT C5A ANTIBODY, IN PATIENTS WITH HIDRADENITIS SUPPURATIVA

" We are pleased to start this study and evaluate the potential of IFX-## in this devastating chronic autoimmune disease.

  • Autoimmune Disease
  • Australia
  • United States
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Rtx-BD Trial (Rituximab of Intractable Autoimmune Bullous Disease Trial) ## Exploratory Research on Effectiveness and Safety of Rituximab Treatment Including Maintenance Administration for Steroid Intractable Autoimmune Bullous Diseases of the Skin (Rtx-BD Trial ##)

  • Autoimmune Disease
  • Dermatology
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.

AUTOIMMUNE DISORDERS ARE ALSO HIGHLIGHTED BY HEIGHTENED IMMUNE RESPONSE AND INFLAMMATORY RESPONSES.

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Celgene Corporation
  • Autoimmune Disease Cirrhosis
  • Indication

Summary Inova Diagnostics, Inc. (Inova) a subsidiary of Werfen Life Group, S.A. is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers for the healthcare sector. The company's diagnostic reagent products include QUANTA Flash which is used for semi-quantitative determination...

  • Autoimmune Disease
  • Diagnostics
  • United States
  • Inova Diagnostics, Inc.
  • Myriad Genetics Inc Pipeline Products Overview

MULTI-BIOMARKER TEST - AUTOIMMUNE DISEASES MULTI-BIOMARKER TEST - AUTOIMMUNE DISEASES PRODUCT OVERVIEW MULTI-BIOMARKER TEST - AUTOIMMUNE DISEASES - PRODUCT STATUS MARKET CATEGORY DEVELOPED BY PIPELINE TERRITORY HIGHEST STAGE OF DEVELOPMENT DEVICE

  • Autoimmune Disease
  • Biomarker
  • Targeted Therapy
  • United States
  • Myriad Genetics, Inc.
  • R&D Progress Research and Development Brief

The presentation focused on Can-Fite' s CF## for the treatment of autoimmune and anti-inflammatory diseases.

  • Autoimmune Disease
  • Therapy
  • World
  • Product Initiative
  • Can-Fite BioPharma Ltd.

RhuDex is a modifying agent for the oral treatment of autoimmune diseases.

  • Autoimmune Disease
  • Japan
  • United States
  • Company
  • Dr. Falk Pharma GmbH
  • different mechanism of action and wherein the composition gives rise to a synergistic effect on the IDO levels.
  • HANSA MEDICAL AB

Kidney Transplant Rejection - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Kidney Transplant Rejection - Pipeline Review, H1 2018, provides an overview of the Kidney Transplant Rejection (Immunology) pipeline landscape. Kidney...

  • Autoimmune Disease
  • Healthcare
  • Therapy
  • United States
  • Product Initiative

SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS (STILL DISEASE) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CLINICAL TRIALS BY PHASE IN E## COUNTRIES SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS (STILL DISEASE) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*

  • Autoimmune Disease
  • Clinical Trial
  • Cytokine
  • World
  • Product Initiative
  • Jul 12, 2018: Landos doses first subject cohort in Phase l trial of BT-11 for IBD
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

(Stage ##) and i. v.

  • Autoimmune Disease
  • Clinical Trial
  • Monoclonal Antibody
  • Therapy
  • World

It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases.

  • Autoimmune Disease
  • Cancer
  • United States
  • Product Initiative
  • Loxo Oncology, Inc.
  • BIOLOGICSMD INC
  • ALOPECIA - PIPELINE BY BIOLOGICSMD INC, H2 2018

Alopecia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Pipeline Review, H2 2018, provides an overview of the Alopecia (Dermatology) pipeline landscape. Alopecia is the partial or complete loss of hair especially...

  • Autoimmune Disease
  • Hair Growth
  • Pharmaceutical
  • United States
  • Product Initiative
  • Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2018

The company develops ethical drugs for autoimmune disease, diabetes and kidney diseases, central nervous system (CNS) diseases and others, and it also develops vaccines.

  • Autoimmune Disease
  • Leukemia
  • World
  • Product Initiative
  • Forma Publishing Group
  • SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS (STILL DISEASE) - PIPELINE BY THERAPEUTIC PROTEINS INTERNATIONAL, LLC, H1 2016
  • SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS (STILL DISEASE) - PIPELINE BY MABION SA, H1 2016

TNFa (Necrosis Factor Alpha) is a major contributor to inflammation in autoimmune diseases.

  • Autoimmune Disease
  • Biosimilar
  • United States
  • Product Initiative
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

An improvement in survival or disease-related symptoms has not been established.

  • Autoimmune Disease
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • Phase III - Trial Details
  • ENANTA PHARMACEUTICALS INC

It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases therapeutic areas.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • BULLOUS PEMPHIGOID - PIPELINE BY IMMUNGENETICS AG, H1 2018
  • BULLOUS PEMPHIGOID - PIPELINE BY TXCELL SA, H1 2018

IND application for the treatment of BP, a rare autoimmune skin disease known to have increased eotaxin-## levels in serum and blister fluids.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • GUILLAIN-BARRE SYNDROME - PIPELINE BY HANSA MEDICAL AB, H1 2018
  • GUILLAIN-BARRE SYNDROME - PIPELINE BY COMPLEMENT PHARMA BV, H1 2018

Guillain-Barre Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Guillain-Barre Syndrome - Pipeline Review, H1 2018, provides an overview of the Guillain-Barre Syndrome (Central Nervous System) pipeline landscape. Guillain-Barre...

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Akari Therapeutics, Plc
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd ## Dec 2002 ## Jul 2008 ## ## ## ## Inosine Monophosphate Dehydrogenase (Inosinic Acid Dehydrogenase or IMP Oxidoreductase or IMPDH or EC ##. ##. ##. ##) Inhibitor Inosine Monophosphate Dehydrogenase (Inosinic Acid Dehydrogenase or IMP Oxidoreductase or IMPDH or EC ##. ##. ##. ##)

  • Autoimmune Disease
  • Cardiology
  • Clinical Trial
  • Hospital
  • World
  • IMMULITE 2000 IMMUNOASSAY SYSTEM - TSI ASSAY - PRODUCT DESCRIPTION
  • IMMULITE 1000 IMMUNOASSAY SYSTEM - TSI ASSAY - PRODUCT DESCRIPTION

Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Thyroid Diagnostic Test - Medical Devices Pipeline Assessment, 2016" provides an overview of Thyroid Diagnostic Test currently in pipeline stage. The report provides comprehensive information...

  • Autoimmune Disease
  • Immunochemistry Test
  • United States
  • Company Financials
  • GlobalData's company
  • VIB-7734 - DRUG PROFILE
  • SYSTEMIC SCLEROSIS (SCLERODERMA) - PIPELINE BY ANIMA BIOTECH LTD, H2 2018

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018, provides an overview of the Systemic Sclerosis (Scleroderma) (Immunology) pipeline landscape. Scleroderma...

  • Autoimmune Disease
  • Chronic Disease
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • FEB 28, 2017: ATLANTIC HEALTHCARE CONFIRMS ALICAFORSEN TARGETS TLR-9, PROVIDING A SECOND MECHANISM OF ACTION TO TREAT NEW AND EXISTING INFLAMMATORY INDICATIONS

TLR-## is a recognized target for the treatment of autoimmune diseases including inflammatory bowel disease (IBD).

  • Autoimmune Disease
  • Healthcare
  • United States
  • World
  • Product Initiative